Danhier, F
The mechanisms through which GLP-1 receptor agonists may reduce inflammation are multifaceted and not yet fully understood
In one clinical trial published in The New England Journal of Medicine , adults with obesity had significant reductions in body weight after 72 weeks of taking tirzepatide
Glutathione and copper, zinc superoxide dismutase are modulated by overexpression of neuronal nitric oxide synthase
Key sources included the US Food & Drug Administration (FDA), European Medicines Agency (EMA), Pharmaceuticals and Medical Devices Agency (PMDA) Japan, Health Canada, Medicines and Healthcare products Regulatory Agency (MHRA) UK, International Diabetes Federation (IDF), American Diabetes Association (ADA), Obesity Society (TOS), European Association for the Study of Diabetes (EASD), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI/PubMed), Centers for Disease Control and Prevention (CDC) National Diabetes Statistics Report, World Health Organization (WHO) Global Health Observatory, OECD Health Statistics, IQVIA National Prescription Audit, Symphony Health prescription data, and national health ministry reports from key markets